|
⚲
|
| Keyboard |
| Andrea Franz | |
|---|---|
| Firm | |
| Address | c/o Kantum Pharma, Inc 75 S Main Street, 7160 Concord, NH 03301 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Kantum Pharma Inc | 021-405951 | Executive Officer | 3.5 M of 3.5 M |
||
| Kantum Diagnostics Inc | 021-323431 | Executive Officer | 0.8 M of 2.0 M |
||
| X4 Pharmaceuticals Inc | 021-298854 | Executive Officer | 35.0 M of 35.0 M |
||
| Civitas Therapeutics Inc | 021-223855 | Executive Officer | 55.2 M of 55.2 M |
||
| Kala Pharmaceuticals Inc | 021-192576 | Executive Officer | 5.8 M of 11.5 M |
||
| Bind Biosciences Inc | 021-169119 | Executive Officer | 25.5 M of 47.3 M |
||
| Bind Biosciences Inc | 021-167172 | Executive Officer | 4.8 M of 4.8 M |
||
| Bind Biosciences Inc | 021-144139 | Executive Officer | 12.4 M of 12.4 M |
||